Cases of invasive pneumococcal disease 'sharply' rose after PHARMAC downgraded vaccine programme - study

Newshub

10 May 2023 - A few years after New Zealand downgraded its vaccine programme against pneumococcal disease, cases of the potentially fatal childhood disease were three times higher than in Australia, new research has found.

A study released on Wednesday morning found PHARMAC's decision to amend the pneumococcal vaccine switch will provide better protection against invasive pneumococcal disease - but warns it may take a few years to see significant improvements.

Read Newshub article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

New Zealand , Vaccine , Supply